AVD

Business Context and Reporting Period

Company: American Vanguard Corp (AMVAC Chemical Corporation)

Filing Type: Form 10-Q (Quarterly Report)

Period Ended: June 30, 2008

Business Overview: The Company manufactures and markets agricultural chemicals, primarily crop protection products. Operations are aggregated into one reportable segment. The Company is an Accelerated Filer and is not a shell company.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 16% for the quarter and 9% for the six-month period compared to 2007. Growth was driven by newly acquired non-crop product lines, despite adverse weather conditions in the Corn Belt.
• Profitability: Net income rose 21% for the quarter ($4.3M vs $3.6M) and 6% for the six-month period ($6.1M vs $5.7M). Operating income for the six months decreased slightly ($12.0M vs $13.2M) due to higher operating expenses.
• Cost Structure: Cost of sales as a percentage of sales increased to 59% (quarter) and 58% (six months) from 56% and 55% respectively in 2007, driven by higher raw material and facility costs.
• Operating Expenses: Increased by $959,000 for the quarter and $1.9M for the six months. Key drivers included increased advertising/promotion ($683k increase YTD), regulatory costs, and intangible amortization from acquisitions.
• Interest Expense: Decreased significantly due to lower effective interest rates (5.1% vs 7.7% YTD) resulting from Federal Reserve rate cuts, despite higher average debt levels.
• Cash Flow: Operating cash flow turned negative ($8.3M used) compared to a positive $37.9M in the prior year. This was primarily due to a $27.3M increase in inventory levels to support new product lines and anticipated demand.

Guidance, Outlook, Risks, and Contingencies

• Outlook: Management notes that quarterly performance can vary significantly due to weather patterns, crop cycles, and product mix. Adverse weather in the Corn Belt continues to impact sales, though non-crop lines remain strong.
• Liquidity: Total indebtedness increased to $87.96M. The Company has $30.5M available on its revolving line of credit and an additional $30M accordion feature on its term loan. All loan covenants were met as of June 30, 2008.
• Legal Proceedings (DBCP): Approximately 90 lawsuits remain pending regarding exposure to the chemical DBCP, primarily in Nicaragua (3,592 claimants) and the US. While AMVAC denies liability, potential damages are significant. Recent court rulings in related cases (Tellez) reversed punitive damages against co-defendants, which the Company is monitoring.
• Other Litigation:
  • McLendon Class Action: A settlement in principle has been reached regarding environmental claims in Georgia for ~2,000 households; no material adverse effect expected.
  • Aceto Litigation: Resolved via acquisition of Aceto's phorate product line in May 2008.
  • Other: Various other suits regarding product defects, employment discrimination, and Parkinson's disease claims are pending but deemed without merit by management at this stage.
• Market Risks: Exposure to raw material price increases, foreign currency fluctuations (hedged via forward contracts), and interest rate changes on variable-rate debt.

Investor Verification Checklist

• Inventory Build: Verify the rationale for the $27.3M increase in inventory and assess the risk of obsolescence or write-downs if demand does not materialize.
• DBCP Litigation Exposure: Monitor the status of the Nicaraguan lawsuits and the outcome of the Ivory Coast appeal, as these represent significant contingent liabilities.
• Margin Compression: Track the ability to pass on rising raw material costs to customers to stabilize gross margins.
• Debt Covenants: Confirm continued compliance with debt covenants given the increased leverage and negative operating cash flow.
• Acquisition Integration: Assess the performance of newly acquired product lines (non-crop) which are driving current revenue growth.